Vaccine Administration Record for Adults (continued)
Before administering any vaccines, give the patient copies of all pertinent Vaccine Information Statements (VISs) and make sure he/she understands the risks and benefits of the vaccine(s). Always provide or update the patient's personal record card.
Patient name Mahamud Omar
Birthdate 5/31/1971 Chart number
PRACTICE NAME AND ADDRESS
Small Rural Clinic
135 County Road D
Small Town, CD 46902
| Vaccine | Type of Vaccine1 | Date vaccine given (mo/day/yr) | Funding Source (F,S,P)2 | Route3 and Site3 | Vaccine | Vaccine Information Statement (VIS) | Vaccinator5 (signature or initials and title) |
|---|
| Lot # | Mfr. | Date on VIS4 | Date given4 |
| Influenza (e.g., IIV3, IIV4, ccIIV3, RIV3, LAIV4)\nGive IIV3, IIV4, ccIIV3, and RIV3 IM.3\nGive LAIV4 NAS.3 | Fluoval | 10/2/2009 | F | IM/RA | 2F600411 | GSK | 8/11/09 | 10/2/09 | PWS |
| H1N1 | 12/7/2009 | P | IM/RA | 10092224P | NOV | 10/2/09 | 12/7/09 | DLW |
| Afluoria | 9/12/2010 | P | IM/RA | 06949111A | CSL | 8/10/10 | 9/12/10 | TAA |
| Fluaval | 10/1/2011 | P | IM/LA | 2F600411 | GSK | 8/10/11 | 10/1/11 | JTA |
| IV3 | 9/5/2012 | P | IM/RA | M50907 | CSL | 7/2/12 | 9/5/12 | KKC |
| RIV3 | 12/2/2013 | P | IM/RA | 350603F | PSC | 7/26/13 | 12/2/13 | DCP |
| IV4 | 10/5/2014 | P | IM/RA | UI196AA | PMC | 8/19/14 | 10/5/14 | JTA |
| IV4 | 11/2/2015 | P | IM/LA | 111773P | NOV | 8/7/15 | 11/2/15 | DCP |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| Pneumococcal conjugate (e.g., PCV13) Give PCV13 IM.3 | PCV13 | 11/1/2012 | P | IM/LA | 7-5096-06A | WYE | 4/16/10 | 11/1/12 | CJP |
| Pneumococcal polysaccharide (e.g., PPSV23)\nGive PPSV23 IM or Subcut.3 | PPSV23 | 9/10/2011 | P | IM/LA | 663012/1163X | MSD | 10/6/09 | 9/10/11 | DLW |
| PPSV23 | 9/15/2015 | P | /LA | 663860/1626X | MSD | 4/24/15 | 9/15/15 | TAA |
| Zoster (HZV) Give Subcut.3 | | | | | | | | | |
| Hib Give IM.3 | AcHIB | 11/1/2011 | P | IM/RA | D05561 | PMC | 2/4/14 | 11/1/14 | MAT |
| Other | | | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
Record the generic abbreviation (e.g., Tdap) or the trade name for each vaccine (see table at right).
Record the funding source of the vaccine given as either F (federal), S (state), or P (private).
Record the route by which the vaccine was given as either intramuscular (IM), subcutaneous (Subcut), intradermal (ID), intranasal (NAS), or oral (PO) and also the site where it was administered as either RA (right arm), LA (left arm), RT (right thigh), or LT (left thigh).
Record the publication date of each VIS as well as the date the VIS is given to the patient.
To meet the space constraints of this form and federal requirements for documentation, a healthcare setting may want to keep a reference list of vaccinators that includes their initials and titles.
| Abbreviation | Trade Name and Manufacturer |
|---|
| IIV3 (inactivated influenza vaccine, trivalent); IIV4 (inactivated influenza vaccine, quadrivalent); ccIIV3 (cell culture-based inactivated influenza vaccine, trivalent); RIV3 (inactivated recombinant influenza vaccine, trivalent) | Fluarix (GSK); Flublok (Protein Sciences Corp.); Afluria, Fluid, Fluclevax, Fluvirin (Seqirus); FluLaval (GSK); Fluzone, Fluzone Intradermal, Fluzone High-Dose (Sanofi Pasteur) |
| LAIV (live attenuated influenza vaccine, quadrivalent) | FluMist (MedImmune) |
| PCV13 | Prevnar 13 (Pfizer) |
| PPSV23 | Pneumovax 23 (Merck) |
| HZV (shingles) | Zostavax (Merck) |
| Hib | ActHIB (Sanofi Pasteur); Hiberix (GSK); PedvaxHib (Merck) |